Press release
Deadline on October 28th coming up in Lawsuit for Investors in Outset Medical, Inc. (NASDAQ: OM)

A Deadline is coming up on October 28, 2024 in the lawsuit for certain investors in Outset Medical, Inc. (NASDAQ: OM).
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and there are strict and short deadlines running. Deadline: October 28, 2024. Outset Medical, Inc. (NASDAQ: OM) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Outset Medical, Inc. (NASDAQ: OM) common shares between August 1, 2022 and August 7, 2024, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 1, 2022 and August 7, 2024, the Defendants failed to disclose to investors, that the Tablo products were marketed for continuous renal replacement therapy, which is not one of the indications approved by the FDA, that, as a result, Outset Medical was reasonably likely to submit an additional 510(k) application for the Tablo products, that there was a substantial risk that the Company would cease sales of the Tablo products pending FDA approval of additional indications, that Outset Medical lacked the sales team and process to execute on the ramp of Tablo sales, that, as a result of the foregoing, the Company's revenue growth would be adversely impacted, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on October 28th coming up in Lawsuit for Investors in Outset Medical, Inc. (NASDAQ: OM) here
News-ID: 3713052 • Views: …
More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…

Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…

Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…

Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Outset
Caramanna, Friedberg LLP Represents Professionals from the outset of any Investi …
Image: https://www.globalnewslines.com/uploads/2025/07/1752223490.jpg
Disciplinary proceedings before a regulatory tribunal can be highly stressful for the professional facing the allegations. This is because these kinds of proceedings can disrupt, suspend or terminate a professional's license to practice their profession. Thus, it is necessary for one to handle such matters with care and fastidious attention to detail. At Caramanna, Friedberg LLP, they can be of help, as their legal team has expertise in representing…
Smart Dialysis System Market Growth Potential is Booming Now: Outset Medical, Me …
The latest study released on the Global Smart Dialysis System Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Smart Dialysis System market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the…
Investigation announced for Long-Term Investors in shares of Outset Medical, Inc …
An investigation was announced for long-term investors in shares of Outset Medical, Inc. (NASDAQ: OM) concerning potential breaches of fiduciary duties by certain directors and officers of Outset Medical, Inc.
Investors who are current long term investors in Outset Medical, Inc. (NASDAQ: OM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors in shares of Outset Medical, Inc. (NASDAQ: OM)
An investor, who purchased shares of Outset Medical, Inc. (NASDAQ: OM), filed a lawsuit alleged violations of Federal Securities Laws by Outset Medical, Inc.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM) have certain options and for certain investors are short and strict deadlines running. Deadline: September 6, 2022. NASDAQ: OM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Jose, CA based Outset…
Investigation announced for Investors in shares of Outset Medical, Inc. (NASDAQ: …
An investigation was announced concerning potential securities laws violations by Outset Medical, Inc. in connection with certain statements.
Investors who purchased shares of Outset Medical, Inc. (NASDAQ: OM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) concerning whether a series…
Hemodialysis Catheter Market – Utilisation Survey 2025 | Toray Medical Co., Lt …
Global Hemodialysis Catheter Market: Overview
Hemodialysis catheters are being extensively used to meet the growing demand of hemodialysis, apheresis, infusion, and monitoring of central venous pressure along with high-pressure contrast injection patients. It is predominantly used for maintaining effective blood flow rate, which is estimated at 400 ml/min for at least 3 hours. The growing number of patients suffering from end-stage renal disease (ESRD) have increased the demand for hemodialysis to…